• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
89.01 2 (1.78%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    87.23

  • Today’s High

    89.41

  • Open

    87.94

  • Perv Close

    87.45

  • 52W Low

    79.49

  • 52W High

    128.90

Key Indicators

  • P/E(TTM)

    30.27

  • Mar.Cap (₹Cr.)

    433.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.10

  • Debt-Equity Ratio

    1.78

  • AGM Date

    29-Apr-2025

  • EPS

    2.92

  • P/E Ratio

    30.27

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    433.71

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    48.73

  • BV (₹)

    48.10

  • Sales( ₹ in Cr.)

    365.47

  • NP (in Cr.)

    16.77

  • NP Var(%)

    -33.0

  • Div%

    0.0

  • CPS (₹)

    6.50

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    430.74

  • 52 Week High

    128.90

  • 52 Week Low

    79.49

  • Price BSE

    88.0

  • Price NSE

    89.00

  • Market Capital( in Cr.)

    430.74

  • P/C Ratio

    13.60

  • P/E Ratio

    25.60

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 365.47 396.53 329.49 303.63 274.32 331.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 365.47 396.53 329.49 303.63 274.32 331.72
Other Income 4.69 6.43 4.51 2.45 4.66 2.05
Stock Adjustments 14.05 -16.46 9.67 1.11 6.40 0.12
Total Income 384.21 386.50 343.67 307.19 285.38 333.89
EXPENDITURE :            
Raw Materials 185.49 182.37 170.02 159.74 149.54 159.63
Power and Fuel Cost 13.47 11.09 9.14 7.04 7.47 7.19
Employee Cost 50.81 46.47 38.63 34.48 34.58 48.14
Other Manufacturing Expenses 31.97 27.30 23.76 19.02 22.37 6.66
Selling and Administration Expenses 51.66 55.69 54.44 43.70 40.96 63.26
Miscellaneous Expenses 6.03 5.95 5.24 9.12 6.01 4.54
Employee Benefit Expenses 50.81 46.47 38.63 34.48 34.58 48.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 339.42 328.87 301.23 273.11 260.94 289.42
Operating Profit 44.79 57.63 42.44 34.08 24.43 44.47
Interest 6.92 5.58 8.31 10.89 12.65 10.59
Gross Profit 37.87 52.05 34.13 23.19 11.78 33.88
Depreciation 14.83 16.13 14.84 14.61 13.27 11.14
Profit Before Tax 23.04 35.92 19.29 8.58 -1.49 22.74
Current Tax 0.83 6.28 3.40 0.02 -0.12 4.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.45 4.63 2.88 2.95 -3.10 1.82
Reported Net Profit 16.76 25.01 13.01 5.62 1.74 16.01
Extraordinary Items -0.01 0.00 0.00 -3.39 -0.01 -0.29
Adjusted Net Profit 16.77 25.01 13.01 9.01 1.75 16.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.49 0.00
P & L Balance brought forward 136.36 111.81 98.76 93.52 92.54 77.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.38 0.46 -0.05 0.39 1.24 1.39
P & L Balance carried down 152.73 136.36 111.81 98.76 93.52 92.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 3.44 5.13 8.01 3.46 1.08 9.93
Earnings Per Share(Adj)-Unit Curr 3.44 5.13 2.67 1.15 0.36 3.31
Book Value 47.60 39.85 104.73 96.69 93.79 93.81
Book Value(Adj)-Unit Curr 47.60 39.85 34.91 32.23 31.26 31.27

Shareholding Pattern

  • Promoter Group

    33.26%

  • Public Share Holding

    66.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,207,980 33.26 16,207,980 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,207,980 33.26 16,207,980 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,171 0.01 5,171 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 115,780 0.24 115,780 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 120,951 0.25 120,951 4
2] Non Institution
Bodies Corporate 3,675,739 7.54 3,627,739 114
Clearing Members 0 0.00 0 0
Directors of their Relatives 722,537 1.48 722,337 10
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,174,953 4.46 640,445 262
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 452,227 0.93 451,627 368
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,233,518 29.21 14,188,398 57
Individuals holding nominal share capital up to Rs. 1 lakh 9,047,672 18.57 8,123,272 16,615
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,748,960 3.59 1,748,960 1
Sub Total 32,396,883 66.49 29,844,055 17,438
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,725,814 100.00 46,172,986 17,448

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015

  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar S Daud

  • Managing Director

    Anwar S Daud

  • Company Secretary

    Piyush Nikhadi

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 88.40 370.16 365.47 30.27 9.99
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92